| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferrin receptor activity | 4.11e-06 | 2 | 41 | 2 | GO:0004998 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 5.95e-05 | 37 | 41 | 3 | GO:0070717 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NCOA2 LHX1 TFCP2L1 HIF3A PER2 RUNX3 HOXD11 EGR3 NEUROD4 ZBTB4 | 1.92e-04 | 1271 | 41 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription corepressor binding | 2.41e-04 | 59 | 41 | 3 | GO:0001222 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA2 LHX1 TFCP2L1 HIF3A PER2 RUNX3 HOXD11 EGR3 NEUROD4 ZBTB4 | 5.80e-04 | 1459 | 41 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | cargo receptor activity | 7.06e-04 | 85 | 41 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.84e-04 | 1244 | 41 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.20e-03 | 25 | 41 | 2 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.40e-03 | 27 | 41 | 2 | GO:0008139 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.53e-03 | 111 | 41 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | poly(A) binding | 1.61e-03 | 29 | 41 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.21e-03 | 34 | 41 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.90e-03 | 39 | 41 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.96e-03 | 140 | 41 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.38e-03 | 303 | 41 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | signal sequence binding | 4.92e-03 | 51 | 41 | 2 | GO:0005048 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 7.19e-03 | 1412 | 41 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 7.88e-03 | 65 | 41 | 2 | GO:0070063 | |
| GeneOntologyCellularComponent | HFE-transferrin receptor complex | 1.04e-04 | 8 | 41 | 2 | GO:1990712 | |
| MousePheno | absent muscle spindles | 1.82e-05 | 3 | 35 | 2 | MP:0008468 | |
| Domain | Peptidase_M28 | 7.94e-09 | 12 | 39 | 4 | PF04389 | |
| Domain | Peptidase_M28 | 7.94e-09 | 12 | 39 | 4 | IPR007484 | |
| Domain | TFR_dimer | 1.68e-07 | 6 | 39 | 3 | PF04253 | |
| Domain | - | 1.68e-07 | 6 | 39 | 3 | 1.20.930.40 | |
| Domain | TFR-like_dimer_dom | 2.93e-07 | 7 | 39 | 3 | IPR007365 | |
| Domain | PA | 7.97e-06 | 19 | 39 | 3 | PF02225 | |
| Domain | PA_domain | 7.97e-06 | 19 | 39 | 3 | IPR003137 | |
| Domain | PAC | 2.12e-05 | 26 | 39 | 3 | SM00086 | |
| Domain | PAC | 2.12e-05 | 26 | 39 | 3 | IPR001610 | |
| Domain | PAS | 4.00e-05 | 32 | 39 | 3 | SM00091 | |
| Domain | PAS | 4.82e-05 | 34 | 39 | 3 | IPR000014 | |
| Domain | PAS | 4.82e-05 | 34 | 39 | 3 | PS50112 | |
| Domain | PAS_fold_3 | 1.05e-03 | 23 | 39 | 2 | IPR013655 | |
| Domain | PAS_3 | 1.05e-03 | 23 | 39 | 2 | PF08447 | |
| Domain | RRM | 1.06e-03 | 217 | 39 | 4 | SM00360 | |
| Domain | PAS | 1.24e-03 | 25 | 39 | 2 | PF00989 | |
| Domain | PAS_fold | 1.24e-03 | 25 | 39 | 2 | IPR013767 | |
| Domain | RRM_dom | 1.25e-03 | 227 | 39 | 4 | IPR000504 | |
| Domain | RRM | 1.31e-03 | 230 | 39 | 4 | PS50102 | |
| Domain | - | 1.63e-03 | 244 | 39 | 4 | 3.30.70.330 | |
| Domain | HLH | 1.81e-03 | 116 | 39 | 3 | SM00353 | |
| Domain | BHLH | 1.86e-03 | 117 | 39 | 3 | PS50888 | |
| Domain | bHLH_dom | 1.90e-03 | 118 | 39 | 3 | IPR011598 | |
| Domain | Nucleotide-bd_a/b_plait | 2.00e-03 | 258 | 39 | 4 | IPR012677 | |
| Domain | Znf_FYVE_PHD | 3.55e-03 | 147 | 39 | 3 | IPR011011 | |
| Domain | CUB | 4.70e-03 | 49 | 39 | 2 | PF00431 | |
| Domain | CUB | 4.89e-03 | 50 | 39 | 2 | SM00042 | |
| Domain | - | 5.27e-03 | 52 | 39 | 2 | 2.60.120.290 | |
| Domain | CUB | 5.47e-03 | 53 | 39 | 2 | PS01180 | |
| Domain | CUB_dom | 6.31e-03 | 57 | 39 | 2 | IPR000859 | |
| Domain | RRM_1 | 9.27e-03 | 208 | 39 | 3 | PF00076 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.61e-09 | 457 | 41 | 9 | 32344865 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31793267 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15987753 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26549031 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21849092 | ||
| Pubmed | Heterotypic interactions between transferrin receptor and transferrin receptor 2. | 1.36e-06 | 2 | 41 | 2 | 12406888 | |
| Pubmed | Lhx1 controls terminal differentiation and circadian function of the suprachiasmatic nucleus. | 1.36e-06 | 2 | 41 | 2 | 24767996 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24901155 | ||
| Pubmed | 1.51e-06 | 709 | 41 | 8 | 22988430 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17956864 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19859668 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 4.06e-06 | 3 | 41 | 2 | 30802453 | |
| Pubmed | The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells. | 4.06e-06 | 3 | 41 | 2 | 19828835 | |
| Pubmed | Stoichiometries of transferrin receptors 1 and 2 in human liver. | 4.06e-06 | 3 | 41 | 2 | 19819738 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12539049 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 34077792 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 35507432 | ||
| Pubmed | The Proprioceptive System Regulates Morphologic Restoration of Fractured Bones. | 4.06e-06 | 3 | 41 | 2 | 28834742 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28017605 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29969719 | ||
| Pubmed | Aluminum exposure affects transferrin-dependent and -independent iron uptake by K562 cells. | 4.06e-06 | 3 | 41 | 2 | 16085060 | |
| Pubmed | Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms. | 4.06e-06 | 3 | 41 | 2 | 29388418 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16893896 | ||
| Pubmed | 4.65e-06 | 1429 | 41 | 10 | 35140242 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 7.24e-06 | 877 | 41 | 8 | 20211142 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 11027676 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 15894659 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 8.12e-06 | 4 | 41 | 2 | 17900573 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 10638746 | ||
| Pubmed | 1.25e-05 | 38 | 41 | 3 | 27820600 | ||
| Pubmed | HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron. | 1.35e-05 | 5 | 41 | 2 | 18353247 | |
| Pubmed | Piezo2 expressed in proprioceptive neurons is essential for skeletal integrity. | 1.35e-05 | 5 | 41 | 2 | 32576830 | |
| Pubmed | The Proprioceptive System Masterminds Spinal Alignment: Insight into the Mechanism of Scoliosis. | 1.35e-05 | 5 | 41 | 2 | 28829946 | |
| Pubmed | 1.56e-05 | 268 | 41 | 5 | 33640491 | ||
| Pubmed | Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. | 1.82e-05 | 43 | 41 | 3 | 25228773 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 9465039 | ||
| Pubmed | 2.32e-05 | 493 | 41 | 6 | 15368895 | ||
| Pubmed | A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. | 2.84e-05 | 7 | 41 | 2 | 18202258 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 6641714 | ||
| Pubmed | 3.13e-05 | 152 | 41 | 4 | 38360978 | ||
| Pubmed | Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. | 3.78e-05 | 8 | 41 | 2 | 7567998 | |
| Pubmed | Ptf1a determines horizontal and amacrine cell fates during mouse retinal development. | 4.86e-05 | 9 | 41 | 2 | 17075007 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 16322559 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 8.37e-05 | 908 | 41 | 7 | 19274049 | |
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 20852008 | ||
| Pubmed | Hoxa11 and Hoxd11 regulate chondrocyte differentiation upstream of Runx2 and Shox2 in mice. | 8.88e-05 | 12 | 41 | 2 | 22916278 | |
| Pubmed | Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. | 8.88e-05 | 12 | 41 | 2 | 25352340 | |
| Pubmed | Lif Deficiency Leads to Iron Transportation Dysfunction in Ameloblasts. | 8.88e-05 | 12 | 41 | 2 | 34034544 | |
| Pubmed | 1.03e-04 | 399 | 41 | 5 | 35987950 | ||
| Pubmed | 1.13e-04 | 407 | 41 | 5 | 12693553 | ||
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 1.26e-04 | 82 | 41 | 3 | 30274258 | |
| Pubmed | 1.31e-04 | 83 | 41 | 3 | 28794006 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.31e-04 | 220 | 41 | 4 | 35785414 | |
| Pubmed | 1.39e-04 | 425 | 41 | 5 | 24999758 | ||
| Pubmed | Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome. | 1.41e-04 | 15 | 41 | 2 | 23064016 | |
| Pubmed | Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity. | 1.41e-04 | 15 | 41 | 2 | 26880306 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 14697343 | ||
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 1.61e-04 | 16 | 41 | 2 | 22069191 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 17301087 | ||
| Pubmed | 1.64e-04 | 233 | 41 | 4 | 37704626 | ||
| Pubmed | Hoxc10 and Hoxd10 regulate mouse columnar, divisional and motor pool identity of lumbar motoneurons. | 1.82e-04 | 17 | 41 | 2 | 18065432 | |
| Pubmed | The role of Sonic hedgehog of neural origin in thalamic differentiation in the mouse. | 2.05e-04 | 18 | 41 | 2 | 19244520 | |
| Pubmed | Midline-derived Shh regulates mesonephric tubule formation through the paraxial mesoderm. | 2.05e-04 | 18 | 41 | 2 | 24370450 | |
| Pubmed | 2.14e-04 | 98 | 41 | 3 | 18557763 | ||
| Pubmed | 2.24e-04 | 253 | 41 | 4 | 29911972 | ||
| Pubmed | Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors. | 2.29e-04 | 19 | 41 | 2 | 15363391 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 19088125 | ||
| Pubmed | 2.77e-04 | 1103 | 41 | 7 | 34189442 | ||
| Pubmed | Onecut1 is essential for horizontal cell genesis and retinal integrity. | 2.81e-04 | 21 | 41 | 2 | 23926259 | |
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 19839995 | ||
| Pubmed | 3.09e-04 | 22 | 41 | 2 | 22326227 | ||
| Pubmed | 3.31e-04 | 513 | 41 | 5 | 25798074 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 18787044 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 18367606 | ||
| Pubmed | 3.68e-04 | 24 | 41 | 2 | 21734270 | ||
| Pubmed | 3.69e-04 | 118 | 41 | 3 | 16971476 | ||
| Pubmed | GDF11 controls the timing of progenitor cell competence in developing retina. | 4.00e-04 | 25 | 41 | 2 | 15976303 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 4.33e-04 | 544 | 41 | 5 | 28473536 | |
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 32071204 | ||
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 28847650 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 5.13e-04 | 315 | 41 | 4 | 26777405 | |
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 23652001 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 5.51e-04 | 321 | 41 | 4 | 32098917 | |
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 21451052 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 5.91e-04 | 327 | 41 | 4 | 15592455 | |
| Pubmed | A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype. | 6.58e-04 | 32 | 41 | 2 | 30926747 | |
| Pubmed | 6.83e-04 | 340 | 41 | 4 | 24332808 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.69e-04 | 351 | 41 | 4 | 38297188 | |
| Pubmed | 7.72e-04 | 152 | 41 | 3 | 34299191 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 11013070 | ||
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 7.87e-04 | 35 | 41 | 2 | 19862010 | |
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 22432025 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 16319116 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 39178848 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 9.28e-04 | 38 | 41 | 2 | 12791264 | |
| Pubmed | 9.28e-04 | 38 | 41 | 2 | 11779826 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 9.45e-04 | 647 | 41 | 5 | 26618866 | |
| Pubmed | 9.85e-04 | 653 | 41 | 5 | 33742100 | ||
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 23362348 | ||
| Interaction | NUP35 interactions | 1.43e-07 | 424 | 41 | 9 | int:NUP35 | |
| Interaction | TLE3 interactions | 9.69e-06 | 376 | 41 | 7 | int:TLE3 | |
| Interaction | ALG13 interactions | 3.36e-05 | 183 | 41 | 5 | int:ALG13 | |
| GeneFamily | Basic helix-loop-helix proteins | 3.10e-04 | 110 | 22 | 3 | 420 | |
| GeneFamily | RNA binding motif containing | 2.10e-03 | 213 | 22 | 3 | 725 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | 1.06e-05 | 412 | 40 | 7 | gudmap_kidney_e15.5_Podocyte_MafB_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 5.02e-05 | 108 | 40 | 4 | gudmap_kidney_e15.5_Podocyte_MafB_k3_500 | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.52e-06 | 120 | 41 | 4 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | Control-B_naive-9|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.98e-06 | 123 | 41 | 4 | 36d509eae874733f1a4f8189ad3000136ff6425e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-05 | 151 | 41 | 4 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 182 | 41 | 4 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 41 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-05 | 187 | 41 | 4 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.65e-05 | 188 | 41 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 189 | 41 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.88e-05 | 192 | 41 | 4 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 192 | 41 | 4 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 80 | 41 | 3 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| Drug | bmep | 9.02e-06 | 3 | 40 | 2 | CID003081158 | |
| Drug | Polylysine | 9.02e-06 | 3 | 40 | 2 | CID000162282 | |
| Drug | cytochalasin B; Down 200; 20.8uM; MCF7; HT_HG-U133A_EA | 1.85e-05 | 187 | 40 | 5 | 1122_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.15e-05 | 193 | 40 | 5 | 6946_DN | |
| Drug | C6-NBD-SM | 3.00e-05 | 5 | 40 | 2 | CID006439924 | |
| Disease | glutaminyl-peptide cyclotransferase measurement | 1.79e-05 | 5 | 40 | 2 | EFO_0802570 | |
| Disease | hematocrit | 5.36e-05 | 1011 | 40 | 8 | EFO_0004348 | |
| Disease | Malignant neoplasm of breast | 8.18e-05 | 1074 | 40 | 8 | C0006142 | |
| Disease | Cooley's anemia | 1.17e-04 | 12 | 40 | 2 | C0002875 | |
| Disease | Thalassemia Minor | 1.17e-04 | 12 | 40 | 2 | C0085578 | |
| Disease | Thalassemia Intermedia | 1.17e-04 | 12 | 40 | 2 | C0271979 | |
| Disease | beta Thalassemia | 1.17e-04 | 12 | 40 | 2 | C0005283 | |
| Disease | iron biomarker measurement, transferrin saturation measurement | 1.61e-04 | 14 | 40 | 2 | EFO_0004461, EFO_0006333 | |
| Disease | cortex volume change measurement | 1.86e-04 | 15 | 40 | 2 | EFO_0021500 | |
| Disease | Hemoglobin F Disease | 1.86e-04 | 15 | 40 | 2 | C0019025 | |
| Disease | transferrin saturation measurement | 2.12e-04 | 16 | 40 | 2 | EFO_0006333 | |
| Disease | superior temporal gyrus volume measurement | 3.02e-04 | 19 | 40 | 2 | EFO_0010331 | |
| Disease | chronic obstructive pulmonary disease | 3.07e-04 | 688 | 40 | 6 | EFO_0000341 | |
| Disease | erythrocyte measurement | 4.02e-04 | 257 | 40 | 4 | EFO_0005047 | |
| Disease | language measurement | 8.00e-04 | 134 | 40 | 3 | EFO_0007797 | |
| Disease | self rated health | 8.13e-04 | 31 | 40 | 2 | EFO_0004778 | |
| Disease | primary dental caries | 9.78e-04 | 34 | 40 | 2 | EFO_0600095 | |
| Disease | Sclerocystic Ovaries | 9.85e-04 | 144 | 40 | 3 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 9.85e-04 | 144 | 40 | 3 | C0032460 | |
| Disease | gait measurement | 1.11e-03 | 150 | 40 | 3 | EFO_0007680 | |
| Disease | Alzheimer disease, polygenic risk score | 1.13e-03 | 586 | 40 | 5 | EFO_0030082, MONDO_0004975 | |
| Disease | FEV/FEC ratio | 1.19e-03 | 1228 | 40 | 7 | EFO_0004713 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.34e-03 | 355 | 40 | 4 | EFO_0004784, EFO_0008354 | |
| Disease | immature reticulocyte measurement | 1.35e-03 | 40 | 40 | 2 | EFO_0803545 | |
| Disease | Hypermetropia, Myopia | 2.15e-03 | 189 | 40 | 3 | HP_0000540, HP_0000545 | |
| Disease | Chronic Lymphocytic Leukemia | 2.54e-03 | 55 | 40 | 2 | C0023434 | |
| Disease | ovarian cancer (is_implicated_in) | 2.63e-03 | 56 | 40 | 2 | DOID:2394 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQNRYPGTPADFNPG | 3846 | Q99996 | |
| PGPTQFFYTEEPQGF | 276 | C9J069 | |
| GTYAGPAPAFQPFFF | 236 | Q6AI12 | |
| QGFSDPSQQPPSYGG | 361 | Q96EP5 | |
| NNGPPFNFPGNFGGS | 716 | Q9NTZ6 | |
| GAPNPTFPNFFPNSA | 251 | Q16769 | |
| FQPAAGGYFVPAVPQ | 401 | Q13310 | |
| PFFDPTGTIYNEGPQ | 3731 | Q86XX4 | |
| PFNNGASYPLQAGQP | 981 | Q96JK9 | |
| PYNVGPGFTGNFSTQ | 326 | Q04609 | |
| TQNGFPAHQAPTYPG | 3071 | Q9UPA5 | |
| YSFPSGTPNLPQAFF | 911 | O15055 | |
| GNYDFFPQGPPSSQA | 291 | P48742 | |
| LAGYTPFANGPNDTP | 616 | Q9UK32 | |
| SYPGANPQPAFGAAE | 546 | A6NF01 | |
| SVSFNQTGPYNDPPG | 1126 | O94913 | |
| QTGPYNDPPGNAFNA | 1131 | O94913 | |
| PSYPGANPQPAFGAA | 961 | Q96HA1 | |
| LGTFTSPNFPNNYPN | 1056 | O60494 | |
| PYAFFTQAGSQQPPP | 351 | Q6UUV9 | |
| PELSYSGSFQPAPGN | 66 | Q06889 | |
| QGFDQFYEAAPGPPF | 176 | P31277 | |
| PPGNPVHGYFEGNNF | 141 | P20851 | |
| PFPNGSFVNGFNSPG | 341 | Q71RC2 | |
| PFFGNGLPQQFPQYQ | 76 | Q9NRM1 | |
| PQAFPPFGNGLFPYQ | 156 | Q9NRM1 | |
| PGYQPQQNGSFGPAR | 276 | P53992 | |
| PYPGAPQNQSGPFQA | 311 | Q13761 | |
| NTGFPSEFQPQPYSD | 91 | Q9H0K4 | |
| SNGNLSSPGFPNGYP | 356 | O43897 | |
| NSANPGFLDYGFAAP | 121 | Q8IYJ0 | |
| PYSDEDTTQPGGPFQ | 646 | Q9Y2N7 | |
| SSPQLYNFSGAAPGP | 261 | Q9ULL5 | |
| PSPSYNGSPNSFGLG | 271 | Q9NZI6 | |
| GDPYTPGFPSFNHTQ | 306 | P02786 | |
| QGTAPVDAFPPNGYG | 276 | Q8NBK3 | |
| FPPNYGISQQPDPGF | 1301 | Q15596 | |
| GVFGYAVNPQAAPPA | 966 | Q9P1Z0 | |
| QSYGPPQGSSFGNQY | 116 | Q9UGU0 | |
| ASPQPFYGNNFEDEP | 76 | Q969M3 | |
| PDYPGSQRNPDFAGS | 126 | Q6UXY8 | |
| GTGDPYTPGFPSFNQ | 326 | Q9UP52 | |
| YTPGFPSFNQTQFPP | 331 | Q9UP52 | |
| NFNYQSPGLPSPPYG | 201 | Q9HD90 |